Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 20,186 | -21,055 | -28,617 | -9,802 | 7,192 |
| Depreciation Amortization | 2,958 | 2,082 | 2,688 | 2,864 | 1,831 |
| Income taxes - deferred | N/A | N/A | N/A | 1,821 | -1,821 |
| Accounts receivable | -1,623 | -863 | 450 | -1,107 | 2,653 |
| Accounts payable and accrued liabilities | N/A | N/A | -709 | 348 | -1,776 |
| Other Working Capital | -33,199 | -26,127 | -24,035 | -28,794 | -20,379 |
| Other Operating Activity | -69,876 | 6,371 | 5,306 | 6,260 | 1,402 |
| Operating Cash Flow | $-81,554 | $-39,592 | $-44,917 | $-28,410 | $-10,898 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -769 | -176 | -2,017 | -275 | 66 |
| Purchase Of Investment | -93,343 | -65,598 | -60,866 | -160,213 | -202,438 |
| Sale Of Investment | 89,830 | 31,499 | 108,637 | 234,837 | 46,750 |
| Purchase Sale Intangibles | -8,000 | N/A | 0 | N/A | N/A |
| Other Investing Activity | -7,755 | 0 | 0 | -600 | 0 |
| Investing Cash Flow | $-12,037 | $-34,275 | $45,754 | $73,749 | $-155,622 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 90,164 | 50,055 | 12 | 25 | 892 |
| Other Financing Activity | -436 | -196 | 0 | 0 | 2,892 |
| Financing Cash Flow | $89,728 | $49,859 | $12 | $25 | $3,784 |
| Beginning Cash Position | 64,764 | 88,772 | 87,923 | 42,559 | 205,295 |
| End Cash Position | 60,901 | 64,764 | 88,772 | 87,923 | 42,559 |
| Net Cash Flow | $-3,863 | $-24,008 | $849 | $45,364 | $-162,736 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,554 | -39,592 | -44,917 | -28,410 | -10,898 |
| Capital Expenditure | -769 | -176 | -2,017 | -275 | N/A |
| Free Cash Flow | -82,323 | -39,768 | -46,934 | -28,685 | -10,898 |